24.04.2017 • NewsElaine BurridgeJohnson MattheyDivision

Johnson Matthey Reorganizes Divisions

© Johnson Matthey 2017
© Johnson Matthey 2017

UK specialty chemical and technology group Johnson Matthey has announced it is reorganizing its corporate divisions with immediate effect. It has retained four divisions but some businesses have been moved to new segments. The Royston-headquartered company said the initiative is designed to increase its focus and build a more collaborative organization as well as reflect its position as a science-led group.

The sectors are now aligned with the global priorities of cleaner air, the efficient use of natural resources and improved health. The former Emission Control Technologies division is now Clean Air, while Process Technologies and much of Precious Metal Products have joined to form the Efficient Natural Resources division. Johnson Matthey said there is an opportunity to deepen its presence in the chemicals, oil and gas, and industrial markets, enabling customers to “make more out of less”.

The new Health business comprises much of the Fine Chemicals division. Johnson Matthey believes it is well positioned to grow in this segment by focusing on niche areas where it can use its expertise in complex chemistry. New Markets encompasses the New Businesses division as well as Medical Components and Catalysis and Chiral Technologies, the latter two were formerly part of Precious Metals and Fine Chemicals, respectively.

In separate news, Johnson Matthey has officially opened a new center for coatings and surface solutions at its West Whiteland site in Chester County, Pennsylvania, USA. The facility, which the company said enables it to enhance the performance of its medical and industrial components, includes a physical vapour deposition laboratory and two process chambers for 2D and 3D coatings.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.